Massage Impact on Sleep in Pediatric Oncology

Description

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Conditions

Cancer, Pediatric Cancer, Chemotherapy Effect, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Pediatric, Hematopoietic Stem Cell Transplantation (HSCT)

Study Overview

Study Details

Study overview

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Massage Impact on Sleep in Hospitalization for Pediatric Oncology and Stem Cell Transplant Patients

Massage Impact on Sleep in Pediatric Oncology

Condition
Cancer
Intervention / Treatment

-

Contacts and Locations

Washington

Children's National Hospital, Washington, District of Columbia, United States, 20010

Philadelphia

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication
  • 2. Expected to be an inpatient for at least 21 days
  • 3. Aged 12 to 21 years at enrollment.
  • 4. Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP).
  • 1. Cognitive impairment sufficient to preclude completing questionnaires appropriately
  • 2. Insufficient knowledge of English or Spanish that would prohibit completing the study instruments
  • 3. Previous enrollment

Ages Eligible for Study

12 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Children's Hospital of Philadelphia,

Tracey Jubelirer, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital of Philadelphia

Study Record Dates

2028-07